CellRapeutics™ Leukopak from Atherosclerosis Donor (XS-0426-XU273)

Name: CellRapeutics™ Leukopak from Atherosclerosis Donor
SKU: XS-0426-XU273
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Procured from donors with clinically significant Atherosclerosis, this Leukopak reflects the chronic, lipid-driven inflammatory state of the arterial wall. The specimen features activated monocyte subsets primed for trans-endothelial migration and foam cell formation. It serves as a primary substrate for investigating the systemic innate-immune drivers of plaque instability and the development of immunotherapies for cardiovascular disease.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Atherosclerosis Donor

Cat. No.
XS-0426-XU273

Donor Age
Middle-Aged, Senior

Donor Health
Diagnosed with progressive vascular plaque formation. Leukocytes exhibit pro-atherogenic priming, particularly within the circulating monocyte population, reflecting chronic vascular wall inflammatory recruitment.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Heparin, optimized to prevent lipid-mediated monocyte activation and stabilize pro-atherogenic immune subsets.

Additional Donor Information
Each lot features a Leukopak from donors with documented atherosclerosis. Comprehensive data include lipid profiles and vascular imaging summaries, enabling researchers to study myeloid cell activation in the context of chronic arterial plaque formation.

Clinical Profile
Evidence of plaque burden via imaging, lipid profile history, and documentation of related vascular complications or interventions.

Additional Information

Medication History
Available upon request. Documentation of statins, antiplatelet agents, and management of associated hypertension or dyslipidemia.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Atherosclerosis Donor, Leukopak, Atherosclerosis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Atherosclerosis Donor (XS-0426-XU273). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.